🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚌En 2023, le bus MICI & MOI reprend la route pour un nouveau tour de France ! Il fera étape au CHRU de Nancy vendredi 23 juin de 10h à 17h pour aider les patients à s'exprimer et échanger avec des professionnels de santé et d'autres patients ➕d'info : afa.asso.fr

La team recherche MICI en direct du #BUSMICI à Nancy afa-Crohn-RCH CHRU de Nancy @JanssenFRA !

A great honor for the IHU INFINY to be invited by The Lancet! thelancet.com/journals/lance…

Ulcerative colitis is a lifelong inflammatory bowel disease with an increasing incidence worldwide. A new Seminar explores current therapeutics options and the pressing need for a personalised approach to successfully treat patients: hubs.li/Q01-P1rh0

The Sequence trial, first positive head to head trial in Crohn's disease comparing ustekinumab versus risankizumab, met all primary and secondary endpoints. news.abbvie.com/news/press-rel…

New insights into IBD trials! "Washout periods in inflammatory bowel disease trials: A systematic literature review and proposed solutions" Vipul Jairath MBChB DPhil Bruce E. Sands Silvio Danese pubmed.ncbi.nlm.nih.gov/37743039/

⁦Fondation ID+ Lorraine⁩ présente aux côté de l’équipe #MICI #IHU Infiny à la fête de la sciences ⁦Lorraine⁩ ⁦FST Nancy⁩. ateliers, conférences, démonstrations toutes plus intéressantes les unes des autres pour le + grand plaisir des petits et grands

Informative collaborative study between GETAID and LYSA. "Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa" pubmed.ncbi.nlm.nih.gov/37850555/

Interesting study from the IOIBD "Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD" pubmed.ncbi.nlm.nih.gov/37864829/

📢 INFINY #IBD Institute was proud to participate with 3 poster presentations at the #ECCO24 Congress 👏 Special thanks to Benedicte Caron, Nina Touly Sailish Honap and Laurent Peyrin-Biroulet for presenting our work to the congress attendees

📢The IHU Infiny teams at #JFHOD2024, presenting impactful studies and expending networks🚀 #IBD #nutrition #IHU

Opposing diet, #microbiome & metabolite mechanisms in IBD. Combo of genetics, reduced dietary fiber &mucin-degrading bacteria triggers IBD. Mucus loss promotes Th1 that drives #colitis. Fiber-free exclusive enteral nutrition prevents colitis @EricCMartens1 cell.com/cell-host-micr…

🤩 Notre équipe est prête à entrer sur le terrain pour la Journée mondiale des #mici, et vous ? RDV le 19 mai pour rendre visibles les MICI 💜 #WorldIBDDay #lesmicientrentenjeux

🔬Congrats to @sash_honap, Laurent Peyrin-Biroulet from INFINY #IBD Institute, and their partners Silvio Danese and @vipuljairathon on their new article in Nature Reviews Drug Discovery! 🚀Let’s keep pushing boundaries! CHRU de Nancy Lorraine Inserm Inserm Est @Grand_Nancy Fondation ID+ Lorraine

Celebrating World IBD Day with a wave of purple! Big shoutout to the IHU INFINY team and AFA, with special thanks to Mireille. Together, we're stronger! 💜 #WorldIBDDay #PurpleWave #IHUINFINY #PatientSupport

[INNOVATION] 🚀Reflecting on the kickoff of i-DEAL, an IHU project developing a new digital care pathway for chronic inflammatory bowel diseases (#IBD) #RHU CHRU de Nancy Lorraine Inserm Est afa-Crohn-RCH #digitalhealth #healthtech #france2030